Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

PCI Pharma Services, (“PCI”)a leading global contract development and manufacturing ...

The level on tariffs on Chinese origin products is astronomical. We also have a 10% tariff on products from Europe, with a carve out for very specific pharmaceutical products. How long that will last ...

Aspen said it related to a manufacturing and technology agreement with a contract manufacturing customer for mRNA products, ...

A unique Novo Nordisk legal challenge to the Medicare drug pricing program could have big implications for the pharma ...

Trump could use the findings of the probe to impose certain trade restrictions on pharma products, including tariffs.

Vishal Manchanda, Pharma Analyst at Systematix Group, advised avoiding companies with high dependence on the US market—such ...

With Trumps tariffs poised to disrupt global pharma trade, industry stakeholders see opportunities for India, provided it ...

Glenmark, Sun Pharma, and Zydus are recalling various products in the US due to manufacturing issues and CGMP deviations, ...